Partial Equity
MCA & GST VerifiedHigh ROI OpportunityProject API-112
API & Intermediates Chemical Synthesis Manufacturing Unit in Chandigarh
25% EBITDA Margins • ₹63.44 Cr ARR • Turnkey Operation
Healthcare & PharmaChandigarh, PunjabEst. 2017 (9 yrs)111 Full-Time Employees30 views today
96% AI Match ScoreStrong Deal Health
Asking Valuation
₹34.89 Cr2.2x EBITDA
Annual Revenue₹63.44 Cr
EBITDA₹15.86 Cr
EBITDA Margin25%
Net Profit₹11.42 Cr
Seller Representation:Verified Founder / Promoter
Advisor Response Rate:Under 2 Hours
Audited Documents:14 Confidential Files
Executive Summary
Highly profitable and established Healthcare & Pharma enterprise operating out of Chandigarh, Punjab. Established in 2017, the company has built a pristine client base, deep operating moats, and verified audited books.
Key Investment Highlights & Competitive Moats
Audited FY25-26 revenue of ₹63.44 Cr with verified 25% EBITDA margins
Pristine compliance history with clean GST, MCA, and Income Tax records
60000 sq.ft (Owned Freehold) modern facility fully equipped with compliant infrastructure
Experienced senior management team remaining post-acquisition for seamless transition
Identified Growth Corridors & Upside Potential
Expansion into Tier-1 export corridors and digital marketplace channels
Capacity utilization currently at 65%, offering immediate upside with existing fixed assets
Strategic synergies for synergistic corporate acquirers and PE roll-up platforms
Hard Assets, Real Estate & IP Included in Sale
- All plant machinery, tools, and compliant operating equipment
- Brand trademarks, proprietary customer contracts, and supplier databases
- Working capital transition support and transfer of operating licenses
Reason for Divestment / Capital Raise
Promoters retiring to focus on philanthropic family office
Similar Verified Opportunities
Curated deals matching similar industry and EBITDA parameters.
Hot DealStrategic Partnership
93% AI MatchStrong Health
KYC VerifiedHigh ROI
US-FDA & WHO-GMP Certified Solid Oral Formulation Plant in Jaipur
Healthcare & Pharma•Jaipur, Rajasthan
Revenue₹49.13 Cr
EBITDA₹10.81 Cr
EBITDA Margin22%
Multiple3.4x EBITDA
12 yrs • 87 team27 views today
Asking Price₹36.75 Cr
Listed 11d ago
Hot DealAsset Sale
94% AI MatchGood Health
DD CertifiedHigh ROI
Diagnostic Lab Chain & Pathology Network across 14 Centers in Indore
Healthcare & Pharma•Indore, Madhya Pradesh
Revenue₹53.02 Cr
EBITDA₹12.19 Cr
EBITDA Margin23%
Multiple3.8x EBITDA
11 yrs • 95 team28 views today
Asking Price₹46.34 Cr
Listed 12d ago
Hot DealFull Buyout
95% AI MatchExcellent Health
DD CertifiedHigh ROI
NABH-Accredited 75-Bed Multi-Specialty Surgical Hospital in Coimbatore
Healthcare & Pharma•Coimbatore, Tamil Nadu
Revenue₹59.03 Cr
EBITDA₹14.17 Cr
EBITDA Margin24%
Multiple4.2x EBITDA
10 yrs • 103 team29 views today
Asking Price₹59.50 Cr
Listed 13d ago